Koers Therapix Biosciences Ltd. Nasdaq
Aandelen
US88339A2033
Farmaceutische producten
Omzet 2022 | 1,35 1,24 | Omzet 2023 | 2,88 2,65 | Marktkapitalisatie | 2,56 mln. 2,36 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -2 mln. -1,84 mln. | Nettowinst (verlies) 2023 | -5 mln. -4,61 mln. | EV/omzet 2022 | 1.145.812 x |
Nettoliquiditeiten 2022 | 3,55 mln. 3,27 mln. | Nettoliquiditeiten 2023 | 5 mln. 4,61 mln. | EV/omzet 2023 | -848.893 x |
K/w-verhouding 2022 |
-1,33
x | K/w-verhouding 2023 |
-0,34
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 99,98% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,91% | 41,97 mld. | |
+22,40% | 22,34 mld. | |
+18,48% | 15,25 mld. | |
+16,12% | 14 mld. | |
+45,12% | 12,06 mld. | |
-0,05% | 6,79 mld. | |
-9,58% | 6,8 mld. | |
-8,87% | 5,73 mld. | |
+14,18% | 5,49 mld. |